Trifocal IOL a key for premium cataract surgery practice
Cathleen M. McCabe, MD, chief medical officer, Eye Health America, and medical director, The Eye Associates, Bradenton, FL, said she began using the IOL as soon as it became available and estimates that she had already implanted it in several hundred eyes within the first six months. Dr. Braga-Mele...
Saved in:
Published in | Ophthalmology Times Vol. 45; no. 8; pp. 15 - 16 |
---|---|
Main Author | |
Format | Trade Publication Article |
Language | English |
Published |
Monmouth Junction
MultiMedia Healthcare Inc
01.05.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Cathleen M. McCabe, MD, chief medical officer, Eye Health America, and medical director, The Eye Associates, Bradenton, FL, said she began using the IOL as soon as it became available and estimates that she had already implanted it in several hundred eyes within the first six months. Dr. Braga-Mele said that she also discusses dysphotopsias with patients, but that the PanOptix IOL seems to be associated with a little better profile than bifocal lenses when it comes to halo and glare. Because it splits light to different foci, reduced contrast sensitivity is another issue to consider. [...]Dr. Braga-Mele and Dr. McCabe exclude patients as candidates for the lens if they have glaucoma or macular pathology affecting vision now or if there is a real risk for progression. |
---|---|
ISSN: | 0193-032X 2150-7333 |